
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 23-Sep-2022 titled Bausch Health and Glenmark Announce the approval of RYALTRIS�� in Canada
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 23-Sep-2022 titled Bausch Health and Glenmark Announce the approval of RYALTRIS�� in Canada
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals